Algernon Pharmaceuticals Inc (AGN.CX)
0.125
+0.02
(+13.64%)
CAD |
CNSX |
May 10, 16:00
Algernon Pharmaceuticals Cash from Operations (TTM): -4.059M for Nov. 30, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| November 30, 2022 | -4.059M |
| August 31, 2022 | -2.913M |
| May 31, 2022 | -2.255M |
| February 28, 2022 | -3.132M |
| November 30, 2021 | -4.061M |
| August 31, 2021 | -7.823M |
| May 31, 2021 | -10.23M |
| February 28, 2021 | -10.65M |
| November 30, 2020 | -9.627M |
| August 31, 2020 | -6.610M |
| May 31, 2020 | -3.671M |
| February 29, 2020 | -1.942M |
| November 30, 2019 | -1.640M |
| Date | Value |
|---|---|
| August 31, 2019 | -1.782M |
| May 31, 2019 | -1.605M |
| February 28, 2019 | -1.302M |
| November 30, 2018 | -0.9911M |
| August 31, 2018 | -0.6165M |
| May 31, 2018 | -0.8752M |
| February 28, 2018 | -0.812M |
| November 30, 2017 | -0.9102M |
| August 31, 2017 | -1.221M |
| May 31, 2017 | -1.378M |
| February 28, 2017 | -1.586M |
| November 30, 2016 | -1.656M |
| August 31, 2016 | -1.408M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.65M
Minimum
Feb 2021
-1.605M
Maximum
May 2019
-4.800M
Average
-3.671M
Median
May 2020
Cash from Operations (TTM) Benchmarks
| Biocure Technology Inc | -0.4423M |
| Core One Labs Inc | -- |
| Nova Mentis Life Science Corp | -- |
| Nanosphere Health Sciences Inc | -0.0378M |
| Lobe Sciences Ltd | -2.279M |